Atropine Sulfate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Atropine Sulfate Injection (injection) from Hospira, Inc., a Pfizer Company with status Current. The shortage was first posted on 01/01/2012.
Shortage Details
- Status
- Current
- Company
- Hospira, Inc., a Pfizer Company
- Package NDC
- 0409-9630-05
- Dosage Form
- Injection
- Presentation
- Atropine Sulfate, Injection, 0.25 mg/5 mL (0.05 mg/mL) Syringes (NDC 0409-9630-05)
- Initial Posting
- 01/01/2012
- Revised Date